Novabridge Biosciences ADR (NBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,696 | -82,217 | -363,526 | -365,870 | 72,170 |
| Depreciation Amortization | 978 | 1,061 | 9,253 | 5,357 | 3,545 |
| Accounts receivable | N/A | N/A | 4,796 | 15,287 | -20,000 |
| Other Working Capital | -2,811 | -37,122 | 80,040 | 61,908 | -36,879 |
| Other Operating Activity | -1,140 | 45,581 | 109,545 | 130,618 | 47,610 |
| Operating Cash Flow | $-52,669 | $-72,697 | $-159,892 | $-152,700 | $66,446 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -84,914 | -15,000 | 73,100 | -108,475 | 1,802 |
| PPE Investments | 62 | N/A | N/A | N/A | N/A |
| Net Acquisitions | N/A | N/A | N/A | N/A | -39,487 |
| Purchase Of Investment | -51,115 | N/A | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | -942 | N/A |
| Purchase Sale Intangibles | -48 | -164 | -6,645 | -4,697 | -1,227 |
| Other Investing Activity | -48 | -164 | -6,641 | -4,697 | 6,742 |
| Investing Cash Flow | $-136,015 | $-15,164 | $66,459 | $-114,114 | $-30,943 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 2,748 | N/A | N/A |
| Common Stock Issued | N/A | 407 | 6,474 | 114,950 | 112,739 |
| Common Stock Repurchased | -335 | -8,644 | -3,081 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | -21,750 | 414,538 |
| Financing Cash Flow | $-335 | $-8,237 | $6,141 | $93,200 | $527,277 |
| Exchange Rate Effect | 573 | 5,197 | 56,429 | -20,207 | -16,344 |
| Beginning Cash Position | 310,667 | 475,371 | 510,879 | 746,756 | 182,879 |
| End Cash Position | 68,263 | 310,667 | 480,016 | 552,935 | 729,315 |
| Net Cash Flow | $-242,404 | $-164,704 | $-30,863 | $-193,821 | $546,436 |
| Free Cash Flow | |||||
| Operating Cash Flow | -52,669 | -72,697 | -159,892 | -152,700 | 66,446 |
| Free Cash Flow | -52,669 | -72,697 | -159,892 | -152,700 | 66,446 |